Your browser doesn't support javascript.
loading
IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis.
Garnier, Laure; Pick, Robert; Montorfani, Julien; Sun, Mengzhu; Brighouse, Dale; Liaudet, Nicolas; Kammertoens, Thomas; Blankenstein, Thomas; Page, Nicolas; Bernier-Latamani, Jeremiah; Tran, Ngoc Lan; Petrova, Tatiana V; Merkler, Doron; Scheiermann, Christoph; Hugues, Stéphanie.
Afiliación
  • Garnier L; Department of Pathology and Immunology, Geneva Medical School, Geneva, Switzerland.
  • Pick R; Department of Pathology and Immunology, Geneva Medical School, Geneva, Switzerland.
  • Montorfani J; Department of Pathology and Immunology, Geneva Medical School, Geneva, Switzerland.
  • Sun M; Department of Pathology and Immunology, Geneva Medical School, Geneva, Switzerland.
  • Brighouse D; Department of Pathology and Immunology, Geneva Medical School, Geneva, Switzerland.
  • Liaudet N; Bioimaging Core Facility, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Kammertoens T; Institute of Immunology, Charité Campus Buch, 13125 Berlin, Germany.
  • Blankenstein T; Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.
  • Page N; Institute of Immunology, Charité Campus Buch, 13125 Berlin, Germany.
  • Bernier-Latamani J; Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.
  • Tran NL; Berlin Institute of Health, 10117 Berlin, Germany.
  • Petrova TV; Department of Pathology and Immunology, Geneva Medical School, Geneva, Switzerland.
  • Merkler D; Department of Pathology and Immunology, Division of Clinical Pathology, University of Geneva and University Hospital of Geneva, Geneva, Switzerland.
  • Scheiermann C; Department of Fundamental Oncology, Ludwig Institute for Cancer Research and Division of Experimental Pathology, University of Lausanne and University of Lausanne Hospital, 1066 Lausanne, Switzerland.
  • Hugues S; Department of Pathology and Immunology, Geneva Medical School, Geneva, Switzerland.
Sci Adv ; 8(23): eabl5162, 2022 06 10.
Article en En | MEDLINE | ID: mdl-35675399
Tumor-associated lymphatic vessels promote metastasis and regulate antitumor immune responses. Here, we assessed the impact of cytotoxic T cells on the local lymphatic vasculature and concomitant tumor dissemination during an antitumor response. Interferon-γ (IFN-γ) released by effector T cells enhanced the expression of immunosuppressive markers by tumor-associated lymphatic endothelial cells (LECs). However, at higher effector T cell densities within the tumor, T cell-based immunotherapies induced LEC apoptosis and decreased tumor lymphatic vessel density. As a consequence, lymphatic flow was impaired, and lymph node metastasis was reduced. Mechanistically, T cell-mediated tumor cell death induced the release of tumor antigens and cross-presentation by tumor LECs, resulting in antigen-specific LEC killing by T cells. When LECs lacked the IFN-γ receptor expression, LEC killing was abrogated, indicating that IFN-γ is indispensable for reducing tumor-associated lymphatic vessel density and drainage. This study provides insight into how cytotoxic T cells modulate tumor lymphatic vessels and may help to improve immunotherapeutic protocols.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interferón gamma / Células Endoteliales Límite: Humans Idioma: En Revista: Sci Adv Año: 2022 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interferón gamma / Células Endoteliales Límite: Humans Idioma: En Revista: Sci Adv Año: 2022 Tipo del documento: Article País de afiliación: Suiza